Food Health TidingsBubs Secures Permanent FDA Authorization for Infant Formula Bubs Secures Permanent FDA Authorization for Infant Formula Read Post »
Health TidingsDD01 Links Dual GLP-1/Glucagon Agonism to Rapid Liver-Fat Reduction DD01 Links Dual GLP-1/Glucagon Agonism to Rapid Liver-Fat Reduction Read Post »
Health TidingsALG-055009 Cuts Liver Fat in MASH Phase 2a Trial ALG-055009 Cuts Liver Fat in MASH Phase 2a Trial Read Post »
Health TidingsGLPG5101 Phase 1 Results Advance Decentralized CAR-T Therapy in B-Cell Lymp... GLPG5101 Phase 1 Results Advance Decentralized CAR-T Therapy in B-Cell Lymp... Read Post »
Clinical Trials Disease & Drugs“Rentosertib May Be Testing the Next Big Idea in Aging: Can a Disease Dru... “Rentosertib May Be Testing the Next Big Idea in Aging: Can a Disease Dru... Read Post »
Health TidingsFDA Withdraws KRAZATI CRC Approval After KRYSTAL-10 Fails FDA Withdraws KRAZATI CRC Approval After KRYSTAL-10 Fails Read Post »
Clinical TrialsSemaglutide Shows Promising BMI Reduction as 40.4% of Children Leave Obesit... Semaglutide Shows Promising BMI Reduction as 40.4% of Children Leave Obesit... Read Post »
Clinical TrialsClover’s RSV Vaccines Show Strong Phase 2 Results in Older Adults Clover’s RSV Vaccines Show Strong Phase 2 Results in Older Adults Read Post »
Food Health TidingsFDA Moves to Protect Neonatal Starter Parenteral Nutrition Supply FDA Moves to Protect Neonatal Starter Parenteral Nutrition Supply Read Post »
Clinical TrialsKylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Ef... Kylo-11 Cuts Lipoprotein(a) by Up to 97% After a Single Dose, Sustaining Ef... Read Post »
Health TidingsRezubio’s RZ-520 Enters Phase 1 After FDA and NMPA Clearances Rezubio’s RZ-520 Enters Phase 1 After FDA and NMPA Clearances Read Post »
ResearchDoes Drinking More Water Really Prevent Kidney Stones? Large Trial Challeng... Does Drinking More Water Really Prevent Kidney Stones? Large Trial Challeng... Read Post »
Drugs Safety AlertEMA Probes Injectable Iron Safety After Reports of Hypophosphataemia and Os... EMA Probes Injectable Iron Safety After Reports of Hypophosphataemia and Os... Read Post »
New Drug ApprovalAstraZeneca Camizestrant Wins FDA Approval in ESR1 Breast Cancer AstraZeneca Camizestrant Wins FDA Approval in ESR1 Breast Cancer Read Post »
Clinical TrialsNovartis’ Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Novartis’ Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Read Post »
GenericsLupin Secures U.S. FDA Approval for Generic Modafinil Tablets (100 mg and 2... Lupin Secures U.S. FDA Approval for Generic Modafinil Tablets (100 mg and 2... Read Post »
Health TidingsIndia SEC Recommends Phase III Waiver for Roche’s 920 mg Subcutaneous Ocr... India SEC Recommends Phase III Waiver for Roche’s 920 mg Subcutaneous Ocr... Read Post »
Clinical TrialsTislelizumab Plus Chemotherapy Shows Sustained Survival in ESCC Tislelizumab Plus Chemotherapy Shows Sustained Survival in ESCC Read Post »
Health TidingsDimerix Secures A$34M Facility for Kidney Disease Programs Dimerix Secures A$34M Facility for Kidney Disease Programs Read Post »
Health TidingsSuperluminal Medicines Raises $60 Million to Advance Selective MC4R Obesity... Superluminal Medicines Raises $60 Million to Advance Selective MC4R Obesity... Read Post »
Clinical TrialsArgo Biopharma’s BW-20805 Cuts HAE Attack Rates by Up to 96% in Phase II ... Argo Biopharma’s BW-20805 Cuts HAE Attack Rates by Up to 96% in Phase II ... Read Post »
Health TidingsFDA Strengthens Global Clinical Trial Oversight on GCP FDA Strengthens Global Clinical Trial Oversight on GCP Read Post »
Health TidingsAnlotinib Fails Noninferiority to Bevacizumab in First-Line mCRC: ANCHOR Tr... Anlotinib Fails Noninferiority to Bevacizumab in First-Line mCRC: ANCHOR Tr... Read Post »
Clinical TrialsNEJM Publishes Daraxonrasib Phase 1/2 Data in RAS-Mutant NSCLC NEJM Publishes Daraxonrasib Phase 1/2 Data in RAS-Mutant NSCLC Read Post »
Clinical TrialsRoche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Pat... Roche’s Vabysmo Sustains Vision Gains and Extends Dosing in Asian PCV Pat... Read Post »
New Drug ApprovalFDA Approves First Treatment for Alexander Disease, Bringing New Hope to Pa... FDA Approves First Treatment for Alexander Disease, Bringing New Hope to Pa... Read Post »
Clinical TrialsOral Gepotidacin Matches Ceftriaxone in NAAT Analysis of Phase 3 Gonorrhea ... Oral Gepotidacin Matches Ceftriaxone in NAAT Analysis of Phase 3 Gonorrhea ... Read Post »
Clinical TrialsBoehringer Ingelheim Announces Nerandomilast Phase 3 IIM Trial Boehringer Ingelheim Announces Nerandomilast Phase 3 IIM Trial Read Post »
Health TidingsMHRA Suspends Avacopan Vifor in New Patients Over Clinical Data Concerns MHRA Suspends Avacopan Vifor in New Patients Over Clinical Data Concerns Read Post »
Health TidingsOwkin Licenses AI Scientist K Pro and Multimodal Patient Data to Boehringer... Owkin Licenses AI Scientist K Pro and Multimodal Patient Data to Boehringer... Read Post »
Clinical TrialsClimb Bio CLYM116 Shows Durable APRIL Suppression in IgAN Climb Bio CLYM116 Shows Durable APRIL Suppression in IgAN Read Post »
Clinical TrialsEtentamig Shows Promising Results in Phase 3 CERVINO Trial for Multiple Mye... Etentamig Shows Promising Results in Phase 3 CERVINO Trial for Multiple Mye... Read Post »
Health TidingsGenglycos (DTX401) Cuts Cornstarch Dependence by 61% at 96 Weeks in GSDIa Genglycos (DTX401) Cuts Cornstarch Dependence by 61% at 96 Weeks in GSDIa Read Post »
Clinical TrialsIvonescimab Shows Overall Survival Benefit in Phase III HARMONi-2 NSCLC Tri... Ivonescimab Shows Overall Survival Benefit in Phase III HARMONi-2 NSCLC Tri... Read Post »
Clinical TrialsApazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome Apazunersen Fails Phase 3 Aspire Trial in Angelman Syndrome Read Post »
Health Tidings Mergers & AcquisitionsHUTCHMED Licenses KRAS-EGFR Therapy to GSK in $1.3 Billion Deal HUTCHMED Licenses KRAS-EGFR Therapy to GSK in $1.3 Billion Deal Read Post »
Clinical TrialsIfebemtinib Plus Garsorasib Shows Promising Activity in KRAS G12C-Mutant Me... Ifebemtinib Plus Garsorasib Shows Promising Activity in KRAS G12C-Mutant Me... Read Post »
Health TidingsCytoSorb Real-World Data Show 37% Reduction in Severe Bleeding During Urgen... CytoSorb Real-World Data Show 37% Reduction in Severe Bleeding During Urgen... Read Post »
Health TidingsFDA Fast Track for BV100 in Drug-Resistant Acinetobacter FDA Fast Track for BV100 in Drug-Resistant Acinetobacter Read Post »
Clinical TrialsCamrelizumab-Rivoceranib Improves Survival Across Age Groups in Unresectabl... Camrelizumab-Rivoceranib Improves Survival Across Age Groups in Unresectabl... Read Post »
Clinical TrialsTeva’s TEV ‘408 Shows Positive Phase 2a Celiac Disease Results Teva’s TEV ‘408 Shows Positive Phase 2a Celiac Disease Results Read Post »
Health TidingsuniQure Files BLA for AMT-130 Gene Therapy in Huntington’s Disease uniQure Files BLA for AMT-130 Gene Therapy in Huntington’s Disease Read Post »
Health TidingsCan-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Phase ... Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Phase ... Read Post »
Health TidingsSHR-A2102 Shows Strong Activity Across Advanced Solid Tumors in Phase 1 Tri... SHR-A2102 Shows Strong Activity Across Advanced Solid Tumors in Phase 1 Tri... Read Post »
Health TidingsTelix Expands Prostate Cancer Imaging With Phase 3 BiPASS Study Telix Expands Prostate Cancer Imaging With Phase 3 BiPASS Study Read Post »
Drugs Safety AlertFDA Adds Boxed Warning to Injectafer Over Serious Hypophosphatemia Risk FDA Adds Boxed Warning to Injectafer Over Serious Hypophosphatemia Risk Read Post »
Clinical TrialsPlixorafenib Shows Positive Interim Results in BRAF Fusion Tumors Plixorafenib Shows Positive Interim Results in BRAF Fusion Tumors Read Post »
Clinical TrialsRezatapopt Shows Promising 46% Response Rate in Ovarian Cancer Rezatapopt Shows Promising 46% Response Rate in Ovarian Cancer Read Post »
Health TidingsZorevunersen Shows Sustained Seizure and Neurodevelopment Benefits Through ... Zorevunersen Shows Sustained Seizure and Neurodevelopment Benefits Through ... Read Post »
Health TidingsAlumis’ Envudeucitinib Misses LUMUS SLE Endpoints, Shows Promise in IFNGS... Alumis’ Envudeucitinib Misses LUMUS SLE Endpoints, Shows Promise in IFNGS... Read Post »
